News

IDIBELL expresses its condolences for the death of the artist Antoni Tapies

The Institute of Bellvitge Biomedical Research (IDIBELL) wishes to express its condolences for the death of Antoni Tàpies on February 6th. In 2005 the artist made in an altruistic way the logo of the research centre, in the same way that years before had made the logo of the Foundation August Pi i Sunyer of […]

Leer más about IDIBELL expresses its condolences for the death of the artist Antoni Tapies

Science vs Cancer

Saturday 4 February is World Cancer Day. This disease is a leading cause of death worldwide. The World Health Organization (WHO) estimates that, without any intervention, 84 million people will die of cancer between 2005 and 2015. The RNE program “En días como hoy”, directed and presented by journalist Juan Ramón Lucas, held a colloquium […]

Leer más about Science vs Cancer

Francesc Posas: “Basic research allows designing more accurate clinical applications”

“Understanding how cells respond to stress, how they realize that there is a dangerous situation and how they put in place the mechanisms to respond.” This is one of the objectives of the laboratory run by Francesc Posas in the Universitat Pompeu Fabra. More specifically, study the functions of these kinases in stress response mechanisms. […]

Leer más about Francesc Posas: “Basic research allows designing more accurate clinical applications”

Emilià Pola: ”2011 has been the best year of IDIBELL, at the worst economic period”

With this sentence the general director of IDIBELL, Emilià Pola, has summarized the general situation of the institution: our scientific production has increased, and also our impact, and we have more competitive projects. On the other side of the scales, the economic crisis means that there is less support and less amount, and it complicates […]

Leer más about Emilià Pola: ”2011 has been the best year of IDIBELL, at the worst economic period”

Manel Esteller, I National Award in Cancer Research ‘Doctores Diz Pintado’

The director of the Cancer Epigenetics and Biology program at IDIBELL and professor of the University of Barcelona, Manel Esteller, has won the ‘I National Award for Research on Cancer Doctores Diz Pintado’ for his scientific career, awarded by the Cancer Research Foundation of the University of Salamanca (Ficus). The award was granted to Esteller […]

Leer más about Manel Esteller, I National Award in Cancer Research ‘Doctores Diz Pintado’

Pedro Montoya: “Chronic pain not only hurts, it also damages the brain”

The researcher Peter Montoya and his team at the University of the Balearic Islands are investigating how brain function changes in patients with chronic pain compared with brain activity in healthy subjects. He explained his latest results on 20 January in the series of seminars IDIBELL. “We do not know how the fire occurs; we […]

Leer más about Pedro Montoya: “Chronic pain not only hurts, it also damages the brain”

Anna Veiga: ”We need very safe iPS cells if we want to use them in the clinic”

The researcher of the Center for Regenerative Medicine in Barcelona, CMR[B], Anna Veiga, explained the latest developments of her research group on “in vitro” models of pluripotency in embryonic stem cells (hESCs) and iPS cells ( induced pluripotent stem cells). It was on January 13 in the cycle of seminars IDIBELL. Since 2005 Veiga directs […]

Leer más about Anna Veiga: ”We need very safe iPS cells if we want to use them in the clinic”

Manel Esteller, International Research Award of Fundación Dexeus, Women’s Health

Manel Esteller, director of the Epigenetics and Cancer Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor has been awarded with the International Research Award of Fundación Dexeus, Women’s Health in its eighth edition. The award honors a person whose career and continuing line of research constitutes a […]

Leer más about Manel Esteller, International Research Award of Fundación Dexeus, Women’s Health

The program Stromalign receives 1.5 million Euros from the European Research Council

The European Research Council (ERC) has awarded with a Starting Grant for scientific excellence Oriol Casanovas, researcher at IDIBELL and at the Catalan Institute of Oncology for the project ‘Mechanisms and Targeting Stromal Tumor Invasion Contribution tone and Metastasis’. The funded project, called Stromalign, focuses on the study of tumor stroma as a possible major […]

Leer más about The program Stromalign receives 1.5 million Euros from the European Research Council
Scroll to Top